Literature DB >> 12540525

Attenuation of the P2Y receptor-mediated control of neuronal Ca2+ channels in PC12 cells by antithrombotic drugs.

Helmut Kubista1, Stefan G Lechner, Angelika M Wolf, Stefan Boehm.   

Abstract

1. In PC12 cells, adenine nucleotides inhibit voltage-activated Ca(2+) currents and adenylyl cyclase activity, and the latter effect was reported to involve P2Y(12) receptors. To investigate whether these two effects are mediated by one P2Y receptor subtype, we used the antithrombotic agents 2-methylthio-AMP (2-MeSAMP) and N(6)-(2-methyl-thioethyl)-2-(3,3,3-trifluoropropylthio)-beta,gamma-dichloromethylene-ATP (AR-C69931MX). 2. ADP reduced A(2A) receptor-dependent cyclic AMP synthesis with half maximal effects at 0.1-0.17 micro M. In the presence of 30 micro M 2-MeSAMP or 100 nM AR-C69931MX, concentration response curves were shifted to the right by factors of 39 and 30, indicative of pA(2) values of 6.1 and 8.5, respectively. 3. The inhibition of Ca(2+) currents by ADP was attenuated by 10-1000 nM AR-C69931MX and by 3-300 micro M 2-MeSAMP. ADP reinhibited Ca(2+) currents after removal of 2-MeSAMP within less than 15 s, but required 2 min to do so after removal of AR-C69931MX. 4. ADP inhibited Ca(2+) currents with half maximal effects at 5-20 micro M. AR-C69931MX (10-100 nM) displaced concentration response curves to the right, and the resulting Schild plot showed a slope of 1.09 and an estimated pK(B) value of 8.7. Similarly, 10-100 micro M 2-MeSAMP also caused rightward shifts resulting in a Schild plot with a slope of 0.95 and an estimated pK(B) of 5.4. 5. The inhibition of Ca(2+) currents by 2-methylthio-ADP and ADPbetaS was also antagonized by AR-C69931MX, which (at 30 nM) caused a rightward shift of the concentration response curve for ADPbetaS by a factor of 3.8, indicative of a pA(2) value of 8.1. 6. These results show that antithrombotic drugs antagonize the inhibition of neuronal Ca(2+) channels by adenine nucleotides, which suggests that this effect is mediated by P2Y(12) receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540525      PMCID: PMC1573666          DOI: 10.1038/sj.bjp.0705037

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells.

Authors:  N Vartian; S Boehm
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

Review 2.  Structure and regulation of voltage-gated Ca2+ channels.

Authors:  W A Catterall
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

3.  ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999.

Authors:  F L Zhang; L Luo; E Gustafson; J Lachowicz; M Smith; X Qiao; Y H Liu; G Chen; B Pramanik; T M Laz; K Palmer; M Bayne; F J Monsma
Journal:  J Biol Chem       Date:  2000-12-04       Impact factor: 5.157

4.  Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.

Authors:  J Simon; P Vigne; K M Eklund; A D Michel; A M Carruthers; P P Humphrey; C Frelin; E A Barnard
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

Authors:  C J Foster; D M Prosser; J M Agans; Y Zhai; M D Smith; J E Lachowicz; F L Zhang; E Gustafson; F J Monsma; M T Wiekowski; S J Abbondanzo; D N Cook; M L Bayne; S A Lira; M S Chintala
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  Identification of the platelet ADP receptor targeted by antithrombotic drugs.

Authors:  G Hollopeter; H M Jantzen; D Vincent; G Li; L England; V Ramakrishnan; R B Yang; P Nurden; A Nurden; D Julius; P B Conley
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

7.  The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.

Authors:  J Jin; W Tomlinson; I P Kirk; Y B Kim; R G Humphries; S P Kunapuli
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

8.  P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells.

Authors:  G Arslan; C M Filipeanu; E Irenius; B Kull; E Clementi; C Allgaier; D Erlinge; B B Fredholm
Journal:  Neuropharmacology       Date:  2000-01-28       Impact factor: 5.250

Review 9.  Inhibition of potassium and calcium currents in neurones by molecularly-defined P2Y receptors.

Authors:  D A Brown; A K Filippov; E A Barnard
Journal:  J Auton Nerv Syst       Date:  2000-07-03

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  12 in total

1.  Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.

Authors:  Kerstin Wirkner; Joana Schweigel; Zoltan Gerevich; Heike Franke; Clemens Allgaier; Edward Leon Barsoumian; Henning Draheim; Peter Illes
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

Review 2.  P2Ys go neuronal: modulation of Ca2+ and K+ channels by recombinant receptors.

Authors:  Stefan Boehm
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

3.  The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.

Authors:  Susanne Horner; Kirsten Menke; Caren Hildebrandt; Matthias U Kassack; Peter Nickel; Heiko Ullmann; Martyn P Mahaut-Smith; Günter Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-09-13       Impact factor: 3.000

4.  Excitatory P2-receptors at sympathetic axon terminals: role in temperature control of cutaneous blood flow.

Authors:  Ivar von Kügelgen
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

Review 5.  Functions of neuronal P2Y receptors.

Authors:  Simon Hussl; Stefan Boehm
Journal:  Pflugers Arch       Date:  2006-05-10       Impact factor: 3.657

Review 6.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

7.  P2Y1 receptors mediate an activation of neuronal calcium-dependent K+ channels.

Authors:  Klaus W Schicker; Giri K Chandaka; Petra Geier; Helmut Kubista; Stefan Boehm
Journal:  J Physiol       Date:  2010-08-02       Impact factor: 5.182

8.  Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors.

Authors:  Liaman K Mamedova; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2006-08-28       Impact factor: 5.858

Review 9.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

10.  Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior.

Authors:  Sacha A Malin; Derek C Molliver
Journal:  Mol Pain       Date:  2010-04-15       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.